Detalhe da pesquisa
1.
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 23(7): 919-930, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35690073
2.
Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.
Lancet Oncol
; 22(2): 277-288, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33357510
3.
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.
Lancet Oncol
; 19(4): 562-578, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29611518
4.
SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer.
Br J Cancer
; 119(11): 1332-1338, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30420616
5.
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations.
Br J Cancer
; 117(9): 1286-1294, 2017 Oct 24.
Artigo
Inglês
| MEDLINE | ID: mdl-28859058
6.
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.
Lancet
; 386(9990): 249-57, 2015 Jul 18.
Artigo
Inglês
| MEDLINE | ID: mdl-26002111
7.
Acquired resistance to anti-EGFR mAb ICR62 in cancer cells is accompanied by an increased EGFR expression, HER-2/HER-3 signalling and sensitivity to pan HER blockers.
Br J Cancer
; 113(7): 1010-9, 2015 Sep 29.
Artigo
Inglês
| MEDLINE | ID: mdl-26372697
8.
A phase 3 trial of bevacizumab in ovarian cancer.
N Engl J Med
; 365(26): 2484-96, 2011 Dec 29.
Artigo
Inglês
| MEDLINE | ID: mdl-22204725
9.
Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial.
Lancet Oncol
; 14(6): 516-24, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23578724
10.
Therapeutic application of monoclonal antibodies in cancer: advances and challenges.
Br Med Bull
; 104: 41-59, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-23118261
11.
Treating patients with dihydropyrimidine dehydrogenase (DPD) deficiency with fluoropyrimidine chemotherapy since the onset of routine prospective testing-The experience of a large oncology center in the United Kingdom.
Semin Oncol
; 49(2): 170-177, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35027218
12.
Long Term Real-World Outcomes of Trifluridine/Tipiracil in Metastatic Colorectal Cancer-A Single UK Centre Experience.
Curr Oncol
; 28(3): 2260-2269, 2021 06 18.
Artigo
Inglês
| MEDLINE | ID: mdl-34207352
13.
HER2 Expression Is Predictive of Survival in Cetuximab Treated Patients with RAS Wild Type Metastatic Colorectal Cancer.
Cancers (Basel)
; 13(4)2021 Feb 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33562755
14.
Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities.
Anticancer Drugs
; 20(10): 851-5, 2009 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-19826350
15.
Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer.
Oncotarget
; 10(18): 1704-1715, 2019 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30899442
16.
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
Health Technol Assess
; 23(64): 1-88, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31852579
17.
Co-expression and prognostic significance of the HER family members, EGFRvIII, c-MET, CD44 in patients with ovarian cancer.
Oncotarget
; 9(28): 19662-19674, 2018 Apr 13.
Artigo
Inglês
| MEDLINE | ID: mdl-29731973
18.
The impact of co-expression of wild-type EGFR and its ligands determined by immunohistochemistry for response to treatment with cetuximab in patients with metastatic colorectal cancer.
Oncotarget
; 8(5): 7666-7677, 2017 Jan 31.
Artigo
Inglês
| MEDLINE | ID: mdl-28032593
19.
Randomized controlled trial of dietary fiber for the prevention of radiation-induced gastrointestinal toxicity during pelvic radiotherapy.
Am J Clin Nutr
; 106(3): 849-857, 2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-28679552
20.
Coexpression of the IGF-IR, EGFR and HER-2 is common in colorectal cancer patients.
Int J Oncol
; 28(2): 329-35, 2006 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-16391786